Product Comparison


 
Allergan Pharmaceutical 00456120230
Allergan Pharmaceutical 00456120130
McKesson # 927214 988635
Description Linzess® Linaclotide 290 mg Capsule Bottle 30 Capsules Linzess® Linaclotide 145 mcg Capsule Bottle 30 Capsules
Manufacturer # 0045612023000456120130
Brand Linzess®Linzess®
Manufacturer Allergan PharmaceuticalAllergan Pharmaceutical
Invoice LINZESS 290MCG CAP (30/BT)LINZESS, CAP 145MCG (30/BT)
    Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 20087202008712
Generic Drug Code 3318833187
NDC Number 0045612023000456120130
Strength 290 mg145 mcg
Application Irritable Bowel Syndrome with Constipation (IBS-C) TreatmentIrritable Bowel Syndrome with Constipation (IBS-C) Treatment
Container Type BottleBottle
Country of Origin UnknownUnknown
Dosage Form CapsuleCapsule
Generic Drug Name LinaclotideLinaclotide
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
UNSPSC Code 5117233751172337
Volume 30 Capsules30 Capsules
Features and Benefits
  • LINZESS® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBS‑C) and chronic idiopathic constipation (CIC)
  • Do not give LINZESS to children who are under 6 years of age - It may harm them
  • You should not give LINZESS to children 6 to 17 years of age - It may harm them
  • LINZESS® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBS‑C) and chronic idiopathic constipation (CIC)
  • Do not give LINZESS to children who are under 6 years of age - It may harm them
  • You should not give LINZESS to children 6 to 17 years of age - It may harm them